58-Year-Old Asymptomatic Man With Left Ventricular Hypertrophy.

[1]  T. Tsang,et al.  Echocardiographic Assessment of Patients with Fabry Disease , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  R. Contri,et al.  Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives , 2016, European Journal of Heart Failure.

[3]  Rajeev Malhotra,et al.  Cardiopulmonary Exercise Testing in Heart Failure. , 2016, JACC. Heart failure.

[4]  B. Gersh,et al.  The Natural History of Nonobstructive Hypertrophic Cardiomyopathy. , 2016, Mayo Clinic proceedings.

[5]  B. Maron,et al.  Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. , 2014, The American journal of cardiology.

[6]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[7]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[8]  G. Mancia,et al.  Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies , 2012, Journal of Human Hypertension.

[9]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.

[10]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[11]  G. Vlahakes,et al.  Management of Symptoms in Hypertrophic Cardiomyopathy , 2008, Circulation.

[12]  W. Manning,et al.  Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[13]  W. Mckenna,et al.  Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy , 2005, Heart.

[14]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.